1 |
Kuiper GG,Enmark E,Peltohuikko M,et al.Cloning of a novel receptor expressed in rat prostate and ovary.Proc Natl A cad Sci USA,1996,93(12):5925-5930.
|
2 |
Lange CA, Richer JK, Shen T, et al. Convergence of progesterone and epidermal growth factor signaling in breast cancer.J Biol Chem, 1998,273(47):31308-31316.
|
3 |
Disis ML,Schiffman K.Cancer vaccines targeting the HER2/neu oncogenic protein.Sem in Oncol,2001,28(6 Suppl 18):12-20.
|
4 |
Têtu B, Brisson J. Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer.The influence of the pattern of immunostaining and adjuvant therapy. Cancer, 1994, 73(9): 2359-2365.
|
5 |
Menard S,Papa SM,Campiglio M,et al.Biologic and therapeutic role of HER2 in cancer.Oncogene,2003,22(42):6570-6578.
|
6 |
Tagliabue E, Agresti R, Ghirelli C, et al. The early relapse of premenopausal patients after surgery for node-positive breast carcinoma.Breast Cancer Res Treat,2001,70(2):155-156.
|
7 |
沈镇宙, 邵志敏. 乳腺肿瘤学. 上海: 上海科学技术出版社,2004.393.
|
8 |
Kunisue H,Kurebayashi J,Otsuki T,et al.Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2. Br J Cancer,2000,82(1):46-51.
|
9 |
Witton CJ, Reeves JR, Going JJ, et al. Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer. J Pathol, 2003,200(3):290-297.
|
10 |
Chung YL,Sheu ML,Yang SC,et al.Resistance to tamoxifen-induced apoptosis ins associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer.Int J Cancer,2002,97(3):306-312.
|
11 |
Dowsett M,Harper-Wynne C, Boeddinghaus I, et al. HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor positive primary breast cancer.Cancer Res,2001,61(23):8452-8458.
|
12 |
Houslon SJ,Plunkell TA,Barnes DM,et al.Overexpression of HER-2 is an independent marker of resistance to endocrine therapy in advanced breast cancer.Br J Cancer,1999,79(7-8):1220-1226.
|
13 |
Mosselman S, Ploman J, Djkema R. ERβ: indentification and characterisation of a novel human estrogen receptor.FEBS Lett,1996,392(1):49-53.
|
14 |
Fuqua SA,Schiff R,Parra I.Estrogen receptor beta protein in human breast cancer:correlation with clinical tumor parameters.Cancer Res,2003,63(10):2434-2439.
|
15 |
Speirs V,Parkes AT,Kerin MJ.Coexpression of estrogen receptor alpha and beta:poor prognostic factors in human breast Cancer?Cancer Res,1999,59(3):525-528.
|
16 |
Park BW,Kim KS,Heo MK,et al.Expression of estrogen receptor-beta in normal mammary and tumor tissues: is it protective in breast carcinogenesis?Breast Cancer Res Treat,2003,80(1):79-85.
|
17 |
Omoto Y,Inoue S,Ogawa S,et al.Clinical value of the wild-type estrogen receptor beta expression in breast cancer.Cancer Letters,2001,163(2):207-212.
|
18 |
Poola I, Clarke R, DeWitty R, et al. Functionally active estrogen receptor isoform profiles in the breast tumors of African American women are different from the profiles inbreast tumors of Caucasian women.Cancer,2002,94(3):615-623.
|
19 |
Lazennec G,Bresson D,Lucas A,et al.ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology, 2001, 142(9): 41 20-4130.
|